Author:
Hoover Dennis J.,Lefker Bruce A.,Rosati Robert L.,Wester Ronald T.,Kleinman Edward F.,Bindra Jasjit S.,Holt William F.,Murphy William R.,Mangiapane Michael L.,Hockel Gregory M.,Williams Ian H.,Smith Ward H.,Gumkowski Michael J.,Shepard Richard M.,Gardner Mark J.,Nocerini Mark R.
Reference35 articles.
1. S. H. Rosenberg, K. P. Spina, S. L. Condon, J. Polakowski, Z. Yao, P. Kovar, H. H. Stein, J. Cohen, J. L. Barlow, V. Klinghofer, D. A. Egan, K. A. Tricarico, T. J. Perun, W. R. Baker, and H. D. Kleinert, Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2–benzyl-3–[[(l-methylpiperazin-4–yl)sulfonyl]-proprionyl]-3–thiazol-4–yl-L-alanine amide of (2S,3R,4S)-2–amino-1–cyclohexyl-3,4–dihydroxy-6–methylheptane (A-72,517), J. Med. Chem. 36: 460–467 (1993).
2. T. Ogihara, J. Higaki, M. Nagano, K. Higashimori, K. Masuo, and H. Mikami, A novel human renin inhibitor with a clinically applicable bioavailability, FK906, Hypertension 20:S423 (1992).
3. H. Umezawa, T. Aoyagi, H. Morishima, M. Matsuzaki, M. Hamada, and T. Takeuchi, Pepstatin, a new pepsin inhibitor produced by actinomycetes, J. Antibiot. 23:259 (1970).
4. D. H. Rich and E. T. O. Sun, Mechanism of the inhibition of pepsin by pepstatin, Biochem. Pharmacol. 29:2205–2212 (1980), and references therein.
5. T. Aoyagi, H. Morishima, R. Nishizawa, S. Kunimoto, T. Takeuchi, H. Umezawa, and K. Ikezawa, Biological activity of pepstatins, pepstatone A and partial peptides on pepsin, cathepsin D, and renin, J. Antibiot. 25: 689–694 (1972).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献